HSCS
Heart Test Laboratories Inc. Common Stock
NASDAQ: HSCS · HEALTHCARE · MEDICAL DEVICES
$1.98
-1.00% today
Updated 2026-04-29
Market cap
$6.40M
P/E ratio
—
P/S ratio
738.41x
EPS (TTM)
$-4.49
Dividend yield
—
52W range
$2 – $6
Volume
0.0M
Heart Test Laboratories Inc. Common Stock (HSCS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | $1.96M | $1.93M | $2.09M | $3.29M | $9.50M | $4.22M |
| Cash & equivalents | $496853.00 | $723481.00 | $918260.00 | $1.66M | $5.81M | $1.10M |
| Current assets | $1.54M | $1.64M | $1.93M | $2.70M | $7.35M | $2.17M |
| Total liabilities | $1.64M | $3.84M | $8.15M | $3.06M | $2.19M | $4.02M |
| Current liabilities | $1.14M | $1.11M | $3.47M | $1.83M | $1.75M | $3.70M |
| Long-term debt | $300000.00 | $2.50M | $4.44M | $500000.00 | — | — |
| Shareholder equity | $315551.00 | $-1.91M | $-6.06M | $230557.00 | $7.32M | $205171.00 |
| Retained earnings | $-47.12M | $-49.57M | $-54.40M | $-60.76M | $-67.36M | $-76.13M |
| Accounts receivable | $131174.00 | $94750.00 | $2321.00 | $319381.00 | $876692.00 | $4350.00 |
| Inventory | $857008.00 | $750774.00 | $674139.00 | $676359.00 | $629179.00 | $650267.00 |
| Goodwill | — | — | — | — | $-1.59B | — |